| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $27.0M | +86.5% |
| R&D Expense | $156.5M | +91.8% |
| SG&A Expense | $60.4M | +22.1% |
| Operating Income | -$189.9M | -62.8% |
| Interest Expense | $3.3M | -2.4% |
| Pre-tax Income | -$179.2M | -56.9% |
| Income Tax | $1.5M | +195.6% |
| Net Income | -$180.7M | -60.3% |
| EPS (Basic) | -$5.08 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $526.4M | +55.2% |
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $561.9M | +52.1% |
| Total Assets | $595.3M | +45.0% |
| Current Liabilities | $69.5M | +30.4% |
| Long-term Debt | $30.7M | +1.3% |
| Total Liabilities | $224.4M | +60.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$60.6M | +29.6% |
| Capital Expenditures | $2.9M | -84.6% |
| Investing Cash Flow | -$2.9M | +84.6% |
| Financing Cash Flow | $250.0M | +3636.2% |
| Free Cash Flow | -$63.6M | +39.5% |
| -33.7% |
| EPS (Diluted) | -$5.08 | -33.7% |
| Stockholders' Equity |
| $370.9M |
| +37.0% |